Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction
Tom E. Verstraelen(Amsterdam University Medical Centers), Arthur A.M. Wilde(Amsterdam Neuroscience), Arjan C. Houweling(ERN GUARD-Heart), Freyja H.M. van Lint(Utrecht University), Virginnio Proost(Amsterdam University Medical Centers), Juan R. Gimeno(Universidad de Murcia), Remco de Brouwer(University Medical Center Groningen), Rudolf A. de Boer(Erasmus MC), Folkert W. Asselbergs(Health Data Research UK), Cathelijne Dickhoff(Westfriesgasthuis), Laurens P. Bosman(Heidelberg University), Karim Taha(Heidelberg University), Aeilko H. Zwinderman(Amsterdam Neuroscience), Paul A. van der Zwaag(University Medical Center Groningen), Maarten P. van den Berg(Regions Hospital), Toon Oomen(St. Antonius Ziekenhuis), B G S Abeln(Amsterdam University Medical Centers), J. Peter van Tintelen(Utrecht University), B. A. Schoonderwoerd(Medisch Centrum Leeuwarden), G. P. Kimman(Noordwest Ziekenhuisgroep)
Cited by 147
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k